Rare Wolf Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Rare Wolf Capital's PFE Position: Q2 2026 in Review
Rare Wolf Capital reduced its Pfizer (PFE) stake by 7.5% in Q2 2026, selling an estimated $196K and leaving 92,920 shares worth $2.24M. The position accounts for 1.44% of the portfolio, ranked #16.
Rare Wolf Capital first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.56M in Q4 2025. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Rare Wolf Capital held 92,920 shares of Pfizer worth $2.24M as of Q2 2026.
- Rare Wolf Capital sold 7,509 Pfizer shares in Q2 2026, an estimated $196K.
- Pfizer made up 1.44% of Rare Wolf Capital's portfolio in Q2 2026, its #16 holding.
- Rare Wolf Capital first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
- Rare Wolf Capital's Pfizer position peaked at $3.56M in Q4 2025.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Rare Wolf Capital's 13F filing for Q2 2026, filed 24 Jul 2026.